Tumor Therapy With An Antibody For Vascular Endothelial Growth Factor And An Antibody For Human Epithelial Growth Factor Receptor Type 2

Patent No. EP2364732 (titled "Tumor Therapy With An Antibody For Vascular Endothelial Growth Factor And An Antibody For Human Epithelial Growth Factor Receptor Type 2") was filed by F Hoffmann LA Roche on Mar 20, 2007. The application was issued on Jul 6, 2016.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GEDEON RICHTER PHARMAApr 5, 2017NEUEFEIND

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2364732

F HOFFMANN LA ROCHE
Application Number
EP11164996A
Filing Date
Mar 20, 2007
Status
Revoked
Feb 21, 2020
Publication Date
Jul 6, 2016